Atypical (7;19) translocation in acute myelomonocytic leukemia.
Chromosome studies were carried out after a 24-hour harvest of unstimulated bone marrow aspirate cell cultures from a 75-year-old male with a clinical diagnosis of acute myelomonocytic leukemia (FAB M4). Analysis of nine cells after trypsin-Giemsa banding (GTG) revealed two cell lines with a mosaic chromosome pattern, 46,XY/46,XY,t(7;19)(q22;p13.3). A review of the recent literature reveals one case of childhood ALL with a 46,XY/46,XY,t(7;19)(q11;q13) chromosome pattern [1] and a 46,XY,t(3q;11q),t(7q;19p),t(15;17)(q26;q22) in one patient with ANLL (FAB M3) [2]. The t(7;19)(q22;p13.3) seen in our case has not been reported as the sole specific clonal chromosome rearrangement in myeloid neoplasia. Interestingly, the plasminogen activator inhibitor type I, multi-drug resistance, and erythropoietin genes are located at band 7q22 and the insulin receptor gene is located at band 19p13.3. Both sites contain fragile site loci. The possible role of these fragile sites, genes, or other genes in the rearrangement can only be surmised.
Sherer
M E
ME
Department of Human Genetics, Univeristy of Pittsburgh, Pennsylvania.
Shekhter-Levin
S
S
Krause
J R
JR
Joyce
R A
RA
Gollin
S M
SM
D000368:Aged; D002869:Chromosome Aberrations / Q000473:pathology*; D025063:Chromosome Disorders; D002888:Chromosomes, Human, Pair 19; D002897:Chromosomes, Human, Pair 7; D006801:Humans; D007621:Karyotyping; D015479:Leukemia, Myelomonocytic, Acute / Q000473:pathology*; D008297:Male; D014178:Translocation, Genetic